Definitions
Sorry, no definitions found. You may find more data at vantia.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Vantia.
Examples
-
The olives are sold under the following brands: Borrelli, Bonta di Puglia, Cento, Corrado's, Dal Raccolto, Flora, Roland and Vantia, and have codes that start with the letter "G" and are followed by 3 or 4 digits.
Recall: There's Botulism In the Olives - The Consumerist 2007
-
The olives are sold under the following brands: Borrelli, Bonta di Puglia, Cento, Corrado's, Dal Raccolto, Flora, Roland and Vantia, and have codes that start with the letter "G" and are followed by 3 or 4 digits.
-
It's been done before - when the Swiss Ferring group closed its Southampton site a few years ago, it gave birth to a new spin-out, Vantia, which today employs nearly as many people.
-
The research study is being sponsored by UK-based Vantia Therapeutics, the company that discovered the investigational drug.
-
The Vantia scientists reasoned that blocking this hormone might relieve dysmenorrhoea.
Telegraph.co.uk: news, business, sport, the Daily Telegraph newspaper, Sunday Telegraph 2010
-
It was discovered by scientists at Vantia Therapeutics from its extensive drug candidate library.
-
April 21 / PRNewswire / -- Vantia Therapeutics, a company developing novel small molecule drugs targeting large underserved medical markets, today announces the appointment of Rachel Morten as Head of Regulatory Affairs.
GEN News Highlights 2009
-
Vantia Therapeutics 'Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia SOUTHAMPTON, England - Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces positive results from a Phase IIa clinical trial of its lead development compound VA106483 for nocturia.
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 2009
-
March 23rd, 2009 SOUTHAMPTON, England - VA106483 Completes Phase IIa Trial and VA111913 Completes Phase I Dosing Vantia Therapeutics, a company focusing on first-in-class therapies for unmet medical needs, announces further clinical trial progress with its two lead development compounds, VA106483 for nocturia associated with benign prostatic hypertrophy (BPH) and VA111913 for dysmenorrhoea.
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 2009
-
Vantia Therapeutics has appointed Rachel Morten as head of regulatory affairs.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.